HPV-RELATED CARCINOMA
Clinical trials for HPV-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
HPV vaccine shields High-Risk women for years, new study shows
⭐️ VACCINE ⭐️ CompletedThis study looked at how well the HPV vaccine protects against cervical, anal, and oral infections in Rwandan women aged 18-28, both with and without HIV. Researchers measured infection rates and antibody levels years after vaccination. The goal is to confirm long-term protection…
Matched conditions: HPV-RELATED CARCINOMA
Sponsor: Montefiore Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:03 UTC
-
New drug combo shows promise against HPV head and neck cancer
Disease control CompletedThis early-stage study tested a new drug called CUE-101, alone or with another drug (pembrolizumab), in 80 people with a type of head and neck cancer linked to HPV. The main goals were to check safety and find the right dose. Researchers also looked at whether the tumors shrank. …
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated May 17, 2026 09:19 UTC